Faeth Therapeutics (FTH) Research & Development (2020 - 2021)
Faeth Therapeutics' (FTH) quarterly Research & Development came in at $3.4 million in Q1 2021, up 53.3% on a YoY basis from $2.2 million in Q1 2020, and up 53.3% quarter-over-quarter from $2.2 million in Q1 2020.
Powered by 
Analysis
Faeth Therapeutics (FTH) Research & Development (2020 - 2021) Analysis & Trends
Faeth Therapeutics (FTH) has reported Research & Development for 2 consecutive years, with $3.4 million the latest figure, recorded in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.76 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 993.80 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.63 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -486.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 651.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 529.60 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 202.02 Mn |
| 10 | Faeth Therapeutics | 218.99 Mn | 218.99 Mn | - | - |